Crossmark

Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy

Crossref DOI link: https://doi.org/10.15252/emmm.201606230

Published Online: 2016-10-28

Published Print: 2017-01

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Benkafadar, Nesrine

Menardo, Julien

Bourien, Jérôme

Nouvian, Régis https://orcid.org/0000-0002-0901-4666
François, Florence

Decaudin, Didier

Maiorano, Domenico https://orcid.org/0000-0003-4229-5903
Puel, Jean‐Luc

Wang, Jing https://orcid.org/0000-0002-2670-719X
Funding

Funding for this research was provided by:

Fondation de l'Avenir pour la Recherche Médicale Appliquée (Et2‐675)

Ministère de l'Enseignement Supérieur, de la Recherche, de la Science et de la Technologie

Institut National de la Santé et de la Recherche Médicale (ENV201508)
License Information

Version of Record valid from 2016-10-28
More Information

Publication History

Received: 2016-01-15

Accepted: 2016-09-26

Published: 2016-10-28